Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

Delayed Quote. Delayed  - 07/27 05:35:12 pm
98.18 EUR   +0.16%
07/26 MERCK KGAA : Biopharma Innovation Cup Honors Young Scientists
07/25 MERCK : Ethiopia Receives 14 Million Praziquantel Tablets
07/18 MERCK KGAA : Darmstadt, Germany Receives European Medicines Agency A..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
07/21/2016 07/22/2016 07/25/2016 07/26/2016 07/27/2016 Date
97.31(c) 97.46(c) 96.95(c) 98.02(c) 98.18(c) Last
402 302 355 360 371 193 391 517 340 304 Volume
+0.95% +0.15% -0.52% +1.10% +0.16% Change
More quotes
Financials (€)
Sales 2016 15 078 M
EBIT 2016 3 252 M
Net income 2016 1 663 M
Debt 2016 10 869 M
Yield 2016 1,24%
Sales 2017 15 469 M
EBIT 2017 3 369 M
Net income 2017 1 782 M
Debt 2017 8 980 M
Yield 2017 1,33%
P/E ratio 2016 24,74
P/E ratio 2017 23,06
EV / Sales2016 1,56x
EV / Sales2017 1,40x
Capitalization 12 668 M
More Financials
Company
Merck KGaA engages in the manufacturing of pharmaceutical and chemical products.The company operates through following divisions: Healthcare, Performance Materials and Life Science, which comprise the Groups six businesses.The Healthcare division is sub divided into Biopharmaceuticals and Consumer... 
Sector
Pharmaceuticals
Calendar
08/04Earnings Release
More about the company
Surperformance© ratings of Merck KGaA
Trading Rating : Investor Rating :
More Ratings
Latest news on MERCK KGAA
07/26 MERCK KGAA : Biopharma Innovation Cup Honors Young Scientists
07/25 MERCK : Ethiopia Receives 14 Million Praziquantel Tablets
07/25 MERCK : Ethiopia Receives 14 Million Praziquantel Tablets Around 23% of Ethiopia..
07/18 MERCK KGAA : Darmstadt, Germany Receives European Medicines Agency Acceptance fo..
07/14 MERCK KGAA : EMD Serono Commits EUR1.5 million to the Grant for Fertility Innova..
07/14 MERCK KGAA : Recent Findings from Merck KGaA Provides New Insights into Fenofibr..
07/13 MERCK KGAA : Advances Water Purification Systems with New High-Throughput Line
07/12 MERCK KGAA : Expands Excipients Portfolio, Adding Polymers for Sustained Release..
07/11 MERCK : and University of Nairobi to Start Medical Oncology Fellowship Program
07/10 MERCK : and University of Nairobi to Start Medical Oncology Fellowship Program M..
More news
Sector news : Specialty & Advanced Pharmaceuticals
04:27pDJFacebook Posts Strong Profit and Revenue Growth
03:45p Teva purchase of Allergan generics business gets OK with conditions
03:37pDJTEVA PHARMACEUTICAL : Allergan Get FTC Approval for Generics Purchase
02:08pDJBAYER : Reports Higher Second-Quarter Profit, Raises Guidance -- 3rd Update
01:11pDJPFIZER : Cleared to Buy Nanotech Drug Firm Bind Therapeutics
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on MERCK KGAA 
2014Prices move higher as positive news are released
2014A gap-filling is anticipated
More Strategies
News from SeekingAlpha
07/18 Merck's marketing application for Cladribine tablets accepted for review in E..
07/06 Late-stage study commences assessing Merck KGaA and Pfizer's avelumab + chemo..
07/05 OneCrinone reproductive treatment approved in Japan
06/24 Sector Licks Its Brexit Wounds
06/24 Eylea Combinations And Array's Play For Melanoma
Advertisement
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 99,0 €
Spread / Average Target 1,00%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefan Oschmann Chief Executive Officer
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Laszlo Radvanyi Senior Vice President & Head-Research
Crocifissa Attardo Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA9.43%13 929
ABBVIE INC8.79%104 239
BIOGEN INC-6.30%62 896
KYOWA HAKKO KIRIN CO L..-0.89%10 467
JAZZ PHARMACEUTICALS P..-1.17%8 403
MALLINCKRODT PLC-10.41%7 310
More Results